Fred Ghali
Pediatric Dermatology · Grapevine, TXNPI 1639286339
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $418,379 of the $623,953 with a category attached, or 67.1%. 35 manufacturers reported payments, led by Sanofi at 40.1% of the total.
Across 1,390 payments — averaging $448.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$250K
- Regeneron Healthcare Solutions, Inc.$156K
- Sanofi-aventis U.S. LLC$49K
- Galderma Laboratories, L.p.$43K
- Incyte Corporation$31K
- Dermavant Sciences, Inc.$26K
- plus $69K from 29 others
Across 175 payments — averaging $1661.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$66K
- Arcutis Biotherapeutics, Inc.$58K
- Ferring Pharmaceuticals AS$54K
- Dermavant Sciences, Inc.$36K
- Incyte Corporation$36K
- Sanofi US Services Inc.$24K
- plus $18K from 4 others
What the payments were for
- Consulting fees$139,65922%
- Speaking & faculty fees$418,37967%
- Travel & lodging$37,6706%
- Food & beverage$28,0104%
- Education$2350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 317 | $250,239 |
| Regeneron Healthcare Solutions, Inc. | 259 | $156,445 |
| Sanofi-aventis U.S. LLC | 14 | $48,547 |
| Galderma Laboratories, L.p. | 103 | $42,718 |
| Incyte Corporation | 74 | $30,569 |
| Dermavant Sciences, Inc. | 23 | $25,979 |
| Organon | 31 | $12,678 |
| Regeneron | 14 | $11,006 |
| Novartis | 10 | $9,831 |
| Arcutis Biotherapeutics, Inc. | 42 | $9,779 |
| AbbVie(2 entities) | 109 | $7,628 |
| Pfizer | 61 | $4,703 |
| EPI Health, LLC | 6 | $3,757 |
| Almirall LLC | 24 | $2,393 |
| Johnson & Johnson | 3 | $1,986 |
| Verrica Pharmaceuticals Inc. | 2 | $1,217 |
| Lilly USA, LLC | 42 | $990 |
| Mayne Pharma Commercial LLC | 123 | $964 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 62 | $871 |
| Sun Pharmaceutical Industries Inc. | 28 | $648 |
| Krystal Biotech Inc | 13 | $270 |
| Amgen | 7 | $241 |
| LEO Pharma Inc. | 4 | $89 |
| LNHC, Inc | 4 | $70 |
| Bristol Myers Squibb | 1 | $57 |
| Nobelpharma America, LLC | 3 | $49 |
| Biofrontera Inc. | 2 | $45 |
| Dermira, Inc. | 2 | $31 |
| Botanix SB Inc | 1 | $28 |
| AstraZeneca | 1 | $25 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $24 |
| Journey Medical Corporation | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric dermatology providers in Texasto place this figure against a meaningful peer group, so we don't.
Other pediatric dermatology in Grapevine
- Adelaide HebertBellaire$1.5M
- Moise LevyAustin$76K
- Neha PuarAustin$23K
- Vicki CarrSpring$22K
- Heather VolkmanFort Worth$9K
- Kerry CarderDallas$4K
- Lucia DiazAustin$4K
- Mark PeakeEl Paso$3K
- Scarlett BoulosBellaire$2K
- Meena JulapalliSpring$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.